A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that ...
Cartesian Therapeutics is a clinical-stage company developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is an mRNA CAR-T in Phase 2b ...
Analyst Mitchell Kapoor of H.C. Wainwright reiterated a Buy rating on Cartesian Therapeutics (RNAC – Research Report), retaining the ...
September/192024/upscnda2-min.jpg" width="1200" height="675" /> NDA 2 Question Paper 2024: The Union Public Service Commission organised the National Defence Academy Exam 2 on 01 September 2024. The ...